Advanced Medicine

Claudia Zylberberg reveals her career lessons learned and offers her perspective on the now booming advanced therapies industry.

Sam Herbert walks us through the past 50 years of pharma logistics.

Welcome to the M Lab™ Collaboration Centers – where customers can use non-GMP lab spaces to operate equipment, evaluate processes and receive...

Will 3D inkjet printing enable the manufacture of personalized tablets?

Nominations are now open for The Medicine Maker 2020 Power List.

As long as payers recognize the value of a curative treatment and manufacturers are flexible with payment plans, patients will have access to ATMPs.

For manufacturers, educating stakeholders, generating evidence and putting the patient first are key to getting value based contracts right.

Are healthcare systems and manufacturers ready to embrace evidence-based pricing to lessen the impact of upfront costs of advanced therapies?

Angela Osborne has created her own space in the industry and is helping the cell and gene therapy industry bloom.

If cell and gene therapy products are to successfully reach patients, then the industry will need more facilities capable of manufacturing them.